Related Experiment Videos
Common variable immunodeficiency (CVID) and inclusion body myositis (IBM)
A Gause1, D C Inderrieden, R Laas
1Poliklinik für Rheumatologie, Universitätsklinikum Lübeck und Krankenhausabteilung der Rheumaklinik Bad Bramstedt, Germany. a.gause@rheuma-zentrum.de
Immunobiology
|September 19, 2000
Summary
A man with common variable immunodeficiency syndrome (CVID) also had inclusion body myositis (IBM). His IBM showed a long, benign course despite IgG infusions, suggesting a potential viral cause for IBM.
Area of Science:
- Neurology
- Immunology
- Rheumatology
Background:
- Common variable immunodeficiency syndrome (CVID) is a primary immunodeficiency characterized by low immunoglobulin levels and impaired B-cell function.
- Inclusion body myositis (IBM) is an acquired inflammatory myopathy typically affecting individuals over 50, presenting with progressive muscle weakness.
Observation:
- A 38-year-old male patient diagnosed with CVID also presented with histologically confirmed IBM.
- The patient's myositis did not improve with regular intravenous immunoglobulin (IgG) infusions, a standard treatment for CVID.
Findings:
- This case highlights an unusually long and benign clinical course of IBM in a younger patient.
- The co-occurrence of CVID and IBM in this patient suggests a potential link, possibly indicating a viral etiology for IBM.
Implications:
- The association between CVID and IBM may serve as a clinical indicator for investigating viral pathogenesis in IBM.
- Further research into this rare co-occurrence could elucidate underlying mechanisms and inform diagnostic or therapeutic strategies for IBM.